These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14622929)

  • 1. Understanding the radiolabelling mechanism of 99mTc-antimony sulphide colloid.
    Tsopelas C
    Appl Radiat Isot; 2003; 59(5-6):321-8. PubMed ID: 14622929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelling of egg meals for gastric emptying studies: a comparison of 99mTc sulfur and 99mTc stannous colloids.
    Shuter B; Ng SM
    Nucl Med Commun; 2005 Apr; 26(4):369-74. PubMed ID: 15753797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabelling and biodistribution of 111In-antimony trisulphide colloid.
    Tsopelas C; Cooper R
    Hell J Nucl Med; 2005; 8(2):109-12. PubMed ID: 16142252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of temperature on the radiochemical purity of 99mTc-colloidal rhenium sulfide for use in sentinel node localization.
    Bensimhon L; Métayé T; Guilhot J; Perdrisot R
    Nucl Med Commun; 2008 Nov; 29(11):1015-20. PubMed ID: 18836382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Efficacy of Sodium [99mTc] Pertechnetate from Low Specific Activity 99Mo/99mTc Autosolex Generator in Hospital Radiopharmacy Centre.
    Mitra A; Chattopadhyay S; Chandak A; Lad S; Barua L; De A; Kumar U; Chinagandham R; Upadhye T; Koundal K; Banerjee S; Rajan R
    Nucl Med Rev Cent East Eur; 2020; 23(1):1-14. PubMed ID: 32779168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle size analysis of (99m)Tc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application.
    Tsopelas C
    J Nucl Med; 2001 Mar; 42(3):460-6. PubMed ID: 11337524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimised radiolabel procedure to prepare (99m)Tc-colloidal rhenium sulphide to improve radiochemical purity.
    Hosten B; Roche R; Barre E; Fouque J; Mouraeff Y; Dumont A; Meur CL; Garrigue H; Hassoun S; Nataf V; Smadja C; de Beco V; Felice K; Rizzo-Padoin N
    Curr Radiopharm; 2011 Apr; 4(2):144-9. PubMed ID: 22191654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-sulfur colloid for lymphoscintigraphy: effects of preparation parameters.
    Eshima D; Eshima LA; Gotti NM; Herda SC; Algozine CA; Burris TG; Vansant JP; Alazraki NP; Taylor AT
    J Nucl Med; 1996 Sep; 37(9):1575-8. PubMed ID: 8790222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of zeta-potential and particle size of technetium 99mTc-sulfur colloid subsequent to the addition of lidocaine and sodium bicarbonate.
    Loveless VS; Surdock CP; Bhattacharjee H
    J Nucl Med Technol; 2010 Mar; 38(1):49-52. PubMed ID: 20159927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of the radiochemical purity of 99mTc-antimony trisulfide colloid prepared by standard and alternative heating methods.
    Smyth DR
    J Nucl Med Technol; 2006 Sep; 34(3):174-8. PubMed ID: 16951287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology.
    Dunn-Dufault R; Pollak A; Thornback JR; Ballinger JR
    Bioconjug Chem; 1999; 10(5):832-7. PubMed ID: 10502350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research of 99mTcO4- and 99mTcO2- in injectable solutions of 99mTc-HMDP by inverse phase HPTLC].
    Jacquot Y; Zoubir B; Xicluna A; Bidet AC
    Ann Pharm Fr; 2006 Jan; 64(1):63-7. PubMed ID: 16449940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized sterile kits for preparation of 99m Tc-labelled albumin, macroalbumin, iron ascorbic acid complex, and antimony sulphide colloid.
    Bruun P
    Scand J Clin Lab Invest; 1971 Nov; 28(3):313-23. PubMed ID: 5135100
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of alternative rapid thin layer chromatography systems for quality control of technetium-99m radiopharmaceuticals.
    Mang'era K; Wong D; Douglas D; Franz K; Biru T
    Appl Radiat Isot; 2014 Apr; 86():57-62. PubMed ID: 24491376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neutrophil labeling techniques using the chemotaxis radioassay.
    English D; Clanton JA
    J Nucl Med; 1984 Aug; 25(8):913-6. PubMed ID: 6086862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc-aprotinin - optimisation and validation of radiolabelling kits for routine preparation for diagnostic imaging of amyloidosis.
    Denholt C; Gillings N
    J Labelled Comp Radiopharm; 2016 Apr; 59(4):171-4. PubMed ID: 26923297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of Tc-99m sestamibi for sentinel node mapping in breast carcinomas: comparison with Tc-99m antimony sulphide colloid.
    Sadeghi R; Zakavi SR; Forghani MN; Aryana K; Kakhki VR; Ayati NK; Shandiz FH; Ghavamnasiri MR; Keshtgar M
    Nucl Med Rev Cent East Eur; 2010; 13(1):1-4. PubMed ID: 21154308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy.
    Hung JC; Wiseman GA; Wahner HW; Mullan BP; Taggart TR; Dunn WL
    J Nucl Med; 1995 Oct; 36(10):1895-901. PubMed ID: 7562061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiopharmaceuticals in sentinel lymph-node detection - an overview.
    Wilhelm AJ; Mijnhout GS; Franssen EJ
    Eur J Nucl Med; 1999 Apr; 26(4 Suppl):S36-42. PubMed ID: 10199931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Randomized Trial of Use of In-House Prepared Low-Cost Radiopharmaceutical Versus Commercial Radiopharmaceutical for Sentinel Lymph Node Biopsy in Patients with Early Stage Invasive Breast Cancer.
    Agarwal G; Rajan S; Mayilvaganan S; Mishra A; Krishnani N; Gambhir S
    World J Surg; 2018 May; 42(5):1391-1395. PubMed ID: 29383426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.